These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8971424)

  • 1. Pharmacokinetics of inhaled drugs.
    Lipworth BJ
    Br J Clin Pharmacol; 1996 Dec; 42(6):697-705. PubMed ID: 8971424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic optimisation of asthma treatment.
    Taburet AM; Schmit B
    Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing inhaled drug delivery in patients with asthma.
    Jackson C; Lipworth B
    Br J Gen Pract; 1995 Dec; 45(401):683-7. PubMed ID: 8745869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution.
    Zainudin BM; Biddiscombe M; Tolfree SE; Short M; Spiro SG
    Thorax; 1990 Jun; 45(6):469-73. PubMed ID: 2392793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
    Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
    Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response of inhaled drugs in asthma. An update.
    Clark DJ; Lipworth BJ
    Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
    Hindle M; Chrystyn H
    Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition.
    Bäckman P; Tehler U; Olsson B
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):108-117. PubMed ID: 27740878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
    Okuda T; Okamoto H
    Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids.
    Kelly HW
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 2):S36-51. PubMed ID: 9798722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.
    Clark DJ; Lipworth BJ
    Thorax; 1996 Oct; 51(10):981-4. PubMed ID: 8977596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
    Martin AR; Moore CP; Finlay WH
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
    Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique.
    Newman SP; Weisz AW; Talaee N; Clarke SW
    Thorax; 1991 Oct; 46(10):712-6. PubMed ID: 1750017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.